In the article entitled “ATM Variant as a Cause of Hereditary Cutaneous Melanoma in a Spanish Family: Case Report” [Case Rep Oncol. 2024;17(1):386–91; DOI: 10.1159/000536105] by Gonzalo Lendinez-Sanchez et al., the authors request the following correction.
Following publication of their article, it was noted that reference 24 of the article [Mucaki EJ, Caminsky NG, Perri AM, Lu R, Laederach A, Halvorsen M, et al. A unified analytic framework for prioritization of non-coding variants of uncertain significance in heritable breast and ovarian cancer. BMC Med Genomics. 2016;9(1):19] was cited incorrectly in the last paragraph by the authors.
Following a discussion between the two author groups, the authors of this article would like to issue a correction to the last paragraph of their article. The last paragraph should be corrected as follows:
“In the bibliography, a similar variant (c.3747–1G>A) has been described in the work of Mucaki et al. [24]. It abolishes the natural acceptor of exon 26, activates a cryptic splice site 13 nucleotides downstream, and would lead to exon skipping and frameshift. In silico analysis predicts skipping of the 246 nt exon, altering the reading frame [24].”
The original online article has been updated to reflect this.
© 2024 The Author(s) Published by S. Karger AG, Basel
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
